Publication details
DEVELOPMENT SAFETY UPDATE REPORT CoVigi 25.2.2023 – 1.11.2023
| Authors | |
|---|---|
| Year of publication | 2023 |
| MU Faculty or unit | |
| Web | CoVigi |
| Description | Objective of the clinical trial CoVigi was to obtain information on the efficacy and safety of COVID-19 vaccines by determining antibody levels and cellular immunity, collecting data on adverse events and effects, and monitoring incidence of COVID-19 disease over the period of 2 years. In addition, the circulating immune profile of oncological patients was monitored and the determined objectives and parameters were evaluated in connection with the type of oncological treatment administered. 559 adult subjects were enrolled in 3 study centers. The trial´s sponsor is the Masaryk University. |
| Related projects: |